Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 20/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1097478 | 0.80 | CCR3 (1.00) | CCR3 | |
| SCHEMBL1097888 | 0.76 | CCR3 (1.00) | CCR3 | |
| SCHEMBL13797759 | 0.74 | CCR3 (0.86) | CCR3 | |
| SCHEMBL4129858 | 0.72 | CCR3 (0.81) | CCR3 | |
| SCHEMBL10094950 | 0.70 | CCR3 (0.70) | CCR3 | |
| SCHEMBL10094949 | 0.69 | CCR3 (0.69) | CCR3 | |
| SCHEMBL4001590 | 0.67 | CCR3 (0.69) | CCR3 | |
| SCHEMBL4000148 | 0.67 | CCR3 (1.00) | CCR3 | |
| SCHEMBL3994282 | 0.67 | CCR3 (0.70) | CCR3 | |
| SCHEMBL1107160 | 0.66 | CCR3 (0.82) | CCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8148403-B2 | Substituted piperidyl-propane-thiols | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-04-03 | — | — | US | disclosed |
| EP-2079731-B1 | NOVEL SUBSTITUTED PIPERIDYL-PROPANE-THIOLS | BOEHRINGER INGELHEIM INT (DE) | 2011-09-14 | — | — | EP | disclosed |
| US-20100317669-A1 | NOVEL SUBSTITUTED PIPERIDYL-PROPANE-THIOLS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317669-A1 | NOVEL SUBSTITUTED PIPERIDYL-PROPANE-THIOLS | CCR3, CCR1, CCRL2 | CCR3 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.